Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

SINOPHARM GROUP CO. LTD.*

國藥控股股份有限公司

(A joint stock limited company incorporated in the People's Republic of China with limited liability and carrying on business in Hong Kong as 國控股份有限公司 )

(Stock Code: 01099)

NOTICE OF BOARD MEETING

The board of directors (the "Board") of Sinopharm Group Co. Ltd. (the "Company") hereby announces that a meeting of the Board will be held on Tuesday, 25 April 2017, for the purpose of considering and approving, among other matters, the quarterly results of the Company and its subsidiaries for the three months ended 31 March 2017.

By order of the Board of

Sinopharm Group Co. Ltd. Li Zhiming

Chairman

Shanghai, the PRC 10 April 2017

As at the date of this announcement, the executive director of the Company is Mr. Li Zhiming; the non-executive directors of the Company are Mr. Chen Qiyu, Mr. She Lulin, Mr. Wang Qunbin, Mr. Ma Ping, Mr. Deng Jindong, Mr. Li Dongjiu, Mr. Lian Wanyong and Mr. Wu Yijian; and the independent non-executive directors of the Company are Ms. Li Ling, Mr. Yu Tze Shan Hailson, Mr. Tan Wee Seng, Mr. Liu Zhengdong and Mr. Zhuo Fumin.

* The Company is registered as a non-Hong Kong company under the Hong Kong Companies Ordinance under its Chinese name and the English name "Sinopharm Group Co. Ltd."

Sinopharm Group Co. Ltd. published this content on 10 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 April 2017 04:24:18 UTC.

Original documenthttp://sinopharm.todayir.com/attachment/2017041012170100002775449_en.PDF

Public permalinkhttp://www.publicnow.com/view/48287C7E3FEDB0FE8E6B799B81E7E1113C6E84C4